Rezatapopt Shows Promise in Restoring Function to Mutant p53 in Early Clinical Trials A fresh study published in Nature Medicine demonstrates that the small molecule rezatapopt can bind to and …
Cancer Therapy
-
-
Vitamin B2 Shows Promise in Sensitizing Cancer Cells to Therapy Vitamin B2, also known as riboflavin, is an essential nutrient vital for energy metabolism and cellular protection. Recent research from …
-
Cancer Interception: New Approach Shows Promise in Pancreatic Cancer Models A new preclinical study in mice demonstrates that eliminating precancerous cells in the pancreas before they develop into tumors is …
-
Predicting and Preventing Breast Cancer Resistance to CDK4/6 Inhibitors Researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified key genetic factors that can predict resistance to CDK4/6 inhibitors, a …
-
Methionine Restriction: A Novel Approach to Cancer Therapy Emerging research suggests that restricting methionine, an essential amino acid, holds promise as a complementary strategy in cancer treatment. By targeting the …
-
Switchable CAR-T Cells Offer New Hope for Cancer Treatment Engineered immune cells, known as chimeric antigen-receptor (CAR) T cells, have revolutionized the treatment of blood cancers, but limitations remain. Researchers …
-
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively. The new approach could be a way to deliver treatment directly …
-
New Insights into Cancer Biology from TUD Research Table of Contents New Insights into Cancer Biology from TUD Research Understanding Cancer Cell Adaptation The Role of Autophagy in Cancer Key …
-
“`html Targeting Apoptosis in Cancer Therapy Targeting Apoptosis in Cancer therapy Table of Contents Targeting Apoptosis in Cancer therapy Understanding Apoptosis and its Role in Cancer Strategies to induce Apoptosis …
-
Promising survival Data Emerges for HER3-Targeting Therapy in Leptomeningeal Metastasis Table of Contents Promising survival Data Emerges for HER3-Targeting Therapy in Leptomeningeal Metastasis The Challenge of Leptomeningeal Metastasis patritumab Deruxtecan: …